OJU1 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Oramed Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 3.885 EUR -0.38% Market Closed

Market Cap: €157.4m

O	Oramed Pharmaceuticals Inc F:OJU1	US
E	Euro Manganese Inc ASX:EMN	CA
	Coast Entertainment Holdings Ltd F:MD8	AU
M	Monro Inc F:MR2	US
I	Internet Gold Golden Lines Ltd TASE:IGLD	IL
	Astra Agro Lestari Tbk PT F:ASX	ID
	Aziel Corp OTC:AZIL	US
	Dominion Minerals Ltd F:1TT0	AU
R	Regenxbio Inc F:RB0	US
	Idex Biometrics ASA F:I8X	NO
G	Greek Organisation of Football Prognostics SA XBER:GF8	GR
E	Edge Total Intelligence Inc XTSX:CTRL	CA
K	Kimura Kohki Co Ltd TSE:6231	JP
	Currency Exchange International Corp F:8YN	US
A	Aurion Resources Ltd XMUN:8RA	CA
	First American Uranium Inc OTC:FAUMD	CA

Profitability Summary

Oramed Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-754%

Low Net Margin

Strong 3Y Average Net Margin

3 203%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-458%

Exceptional ROE

58%

Exceptional 3Y Average ROE

45%

Negative ROIC

-7%

Negative 3Y Average ROIC

-8%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.